Breast cancer treatment technology provider Devicor Medical Products and Faxitron Bioptics have announced a new distribution agreement.
Devicor will now distribute Faxitron's CoreVision core specimen radiography system, which is marketed to breast radiologists and surgeons. The device verifies the presence of microcalcifications in core biopsies, confirming a successful biopsy procedure directly in the stereotactic biopsy suite, according to the firm.
The agreement includes the newly cobranded Mammotome CoreVision within the U.S., with pending distribution in other countries in Europe and Asia, Devicor said.
